Search results
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 10 hours agoThe companies have already reported promising data from their study in melanoma, and are also...
U.S. FDA aiming for speedy review of Omicron vaccines and drugs - WSJ
AOL· 21 hours agoThe U.S. Food and Drug Administration is setting up guidelines to expedite reviews of COVID-19...
COVID-19 Fall Outlook
The National Law Review· 2 weeks agoMuch of the U.S. is currently in the thick of the first uptick in COVID-19 cases in several months. Driven by a new variant, “Eris” (or EG.5), the spike in cases could presage a fall or winter ...
China’s drugmakers can’t sell mRNA shots but haven’t quit yet
WSAU Wausau· 6 days agoBy Andrew Silver SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 1 week ago...At the same time, the National Academies of Sciences, Engineering, and Medicine (NASEM) committee...
COVID-19 On Steep Decline, But Physicians Advise Public To Continue Vaccines
Houston Press· 1 week ago“We expect it to continue to be like this for a few months,” said Dr. Luis Ostrosky, chief of infectious diseases and epidemiology at UTHealth Houston. Ostrosky said people ...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...